Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 99.50
Bid: 99.00
Ask: 100.00
Change: 0.00 (0.00%)
Spread: 1.00 (1.01%)
Open: 99.00
High: 100.00
Low: 99.00
Prev. Close: 99.50
CNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results for the year ended 31 December 2015

18 Mar 2016 07:00

RNS Number : 5000S
Concurrent Technologies PLC
18 March 2016
 

18 March 2016

Concurrent Technologies Plc

(the "Company" or the "Group")

 

Results for the year ended 31 December 2015

 

Concurrent Technologies Plc (AIM: CNC), a world leading specialist in the design and manufacture of high-end embedded computer products, for critical applications in the defence, aerospace, transportation, telecommunications, scientific and industrial markets, announces results for the year to 31 December 2015.

 

Financial Highlights

 

· Turnover increased by 33.6% to £17.1m (2014: £12.8m)

· EBITDA increased by 40.0% to £4.2m (2014: £3.0m)

· Profit before Tax increased by 58.8% to £2.7m (2014: £1.7m)

· Cash in business plus deposits increased by 5.4% to £5.9m (2014: £5.6m)

· EPS increased by 66.2% to 3.79 pence (2014: 2.28 pence)

· Dividend increased by 5.56% to 1.90 pence per share for the year (2014: 1.80 pence)

 

Operational Highlights

 

· Continued success of sales associated with telecommunications base station test equipment using AMC architecture.

· 84% growth in sales of products associated with scientific applications.

· 25% improvement in VPX™ architecture product sales mainly for defence applications.

· 7 new high performance processor boards, featuring the latest technology including 4th generation Intel® Core™ processors, low power Intel® Atom™ processors and latest Intel® Xeon® processors.

· Launch of GPU (Graphics Processing Unit) accelerator board to augment AMC boards.

· Investment in new equipment for manufacturing.

 

Michael Collins, Chairman, commented:

 

"We are a key supplier of Intel based technology to many major international companies and our products are used in a wide range of ever more sophisticated and high-reliability computer systems. While the outlook for the current worldwide economic climate is not clear, our core business is relatively resilient and there are many opportunities to introduce our highly innovative technology to new customers. We will continue our investment in R&D to ensure a constant expansion of our range of advanced technology products and thereby enhance our competitive position."

"Our objective remains to design more innovative products for complex, high technology, low to medium volume and high margin applications, including versions for use in harsh environments. Work has already started on the next generation of high performance processor boards and we continue to advance the capabilities of these products with new and complementary software and firmware packages providing security and high-speed data transfers together with simple integration."

"Sales in the first quarter of 2016 have been excellent and our current order book indicates a strong first half year performance."

 

Annual General Meeting

 

The annual general meeting of Concurrent Technologies Plc will be held at the Company's offices at 4 Gilberd Court, Newcomen Way, Colchester, Essex, CO4 9WN, on 19 May 2016 at 2:30pm.

 

Enquiries:

 

Concurrent Technologies Plc

+44 (0)1206 752 626

Glen Fawcett, CEO

Newgate (Financial PR)

Bob Huxford

+44 (0)207 653 9850

Robyn McConnachie

Cenkos Securities plc (NOMAD)

Neil McDonald

+44 (0)131 220 9771

Nick Tulloch/Beth McKiernan

+44 (0)131 220 9772/8

Extracts from the Strategic Report

Review of Operations

The Group achieved excellent results in 2015, with record sales of £17.07m (2014: £12.81m) and profit before tax of £2.73m (2014: £1.72m). Earnings per share were 3.79 pence (2014: 2.28 pence).

The Group EBITDA (measured as Operating Profit plus Depreciation and Amortisation) for 2015 was £4.17m (2014: £3.00m). The gross margin for the year was 50.6% (2014: 51.2%).

The successful sales of AMC architecture computers for telecommunications test equipment in 2014 continued into 2015 and overall sales for telecommunications applications grew by 45%. In 2015, there was also continued growth of sales associated with scientific applications, particularly for physics research projects, which have increased by 84%. In addition, sales for defence related applications grew by 27% as compared to 2014, mainly due to increased revenues from the USA. Exports increased by 24% as compared to 2014.

We continued to increase our investment in R&D from £2.76m in 2014 to £3.05m in 2015, of which £2.20m was capitalised (2014: £2.09m).

The Group continues to have no borrowings. We have again paid increased dividends during the year and our cash balances plus short to medium term cash deposits at the year-end improved to £5.87m (2014: £5.62m).

Operational Highlights

Seven new high performance embedded computers were released during the year, featuring the latest technology processors including the new generation Intel® Xeon® processors. As well as providing the latest high performance and low power units across all of our architectures for new applications and new customers, these computer boards also allow for practical upgrade paths for our existing long life cycle customers. In addition to these main computer boards, we also released further accessory boards to supplement the functionality of our main products providing, for example, faster and easier network connectivity and additional data storage.

During the year we launched our first GPU (Graphics Processing Unit) accelerator board or accelerator engine which offers a very high level of parallel processing to augment the processing capability of our current Intel® processor based AMC boards. Typical GPU accelerated computing applications include video transcoding, wireless test and infrastructure, image analysis and recognition, ISR (Intelligence, Surveillance and Reconnaissance), high speed physics experiments, simulations and encryption/decryption, where size, modularity, environmental requirements and power consumption make it impractical to use standard server based equipment.

There has also been continuing growth (25% in the year under review) in sales for our VPX™ architecture boards, which are mainly used in defence and surveillance related applications, including unmanned vehicles.

Due to the increase in production volumes, we acquired an additional pick-and-place module early in 2015, for the very fast placement of common components on boards. This has helped to speed up production throughput and avoid capacity issues.

Future Plans

We are a key supplier of Intel based technology to many major international companies and our products are used in a wide range of ever more sophisticated and high-reliability computer systems. While the outlook for the current worldwide economic climate is not clear, our core business is relatively resilient and there are many opportunities to introduce our highly innovative technology to new customers. We will continue our investment in R&D to ensure a constant expansion of our range of advanced technology products and thereby enhance our competitive position.

Our objective remains to design more innovative products for complex, high technology, low to medium volume and high margin applications, including versions for use in harsh environments. Work has already started on the next generation of high performance processor boards and we continue to advance the capabilities of these products with new and complementary software and firmware packages providing security and high-speed data transfers together with simple integration.

Sales in the first quarter of 2016 have been excellent and our current order book indicates a strong first half year performance.

Dividend

The Board has declared a second interim dividend of 1.20 pence per share (2014: 1.15 pence) which when added to the first interim dividend of 0.70 pence per share (2014: 0.65 pence) will make a total of 1.90 pence per share for the year (2014: 1.80 pence). This is an increase of 5.56% on dividends paid for 2014. The total cost of this second interim dividend will amount to £870,942. As in previous years, the Directors do not intend to recommend a final dividend. In order to account for the Easter holidays and to allow for our dividend payment to be scheduled as normal, the London Stock Exchange has agreed that the ex-dividend date for the final dividend is 29 March 2016 and the associated record date is 30 March 2016; the dividend payment date is 5 April 2016.

Annual General Meeting

The annual general meeting of Concurrent Technologies Plc will be held at the Company's offices at 4 Gilberd Court, Newcomen Way, Colchester, Essex, CO4 9WN, on 19 May 2016 at 2:30pm.

 

All companies and product names are trademarks of their respective organisations.

 

Consolidated Statement of Comprehensive Income

Year to

Year to

31 December

31 December

2015

2014

CONTINUING OPERATIONS

£

£

Revenue

17,073,829

12,806,315

Cost of sales

8,437,564

6,247,748

Gross profit

8,636,265

6,558,567

Operating expenses

5,945,140

4,892,800

Group operating profit

2,691,125

1,665,767

Finance income

42,292

58,079

Profit before tax

2,733,417

1,723,846

Tax

(21,351)

76,148

Profit for the year

2,754,768

1,647,698

Other Comprehensive Income

Items that will be reclassified subsequently to profit or loss:

Exchange differences on translating foreign operations

62,918

90,539

Tax relating to components of other comprehensive income

-

-

Other Comprehensive Income for the year, net of tax

62,918

90,539

Total Comprehensive Income for the year

2,817,686

1,738,237

Profit for the period attributable to:

Equity holders of the parent

2,754,768

1,647,698

Total Comprehensive Income attributable to:

Equity holders of the parent

2,817,686

1,738,237

Earnings per share

Basic earnings per share

3.79p

2.28p

Diluted earnings per share

3.79p

2.28p

 

Consolidated Balance Sheet

As at

As at

31 December

31 December

2015

2014

£

£

ASSETS

Non-current assets

Property, plant and equipment

690,357

608,044

Intangible assets

6,307,044

6,018,931

Deferred tax assets

129,647

73,440

7,127,048

6,700,415

Current assets

Inventories

3,774,285

2,699,658

Trade and other receivables

2,520,573

2,790,426

Current tax assets

284,419

307,912

Other financial assets

1,000,000

-

Cash and cash equivalents

4,873,815

5,624,505

12,453,092

11,422,501

Total assets

19,580,140

18,122,916

LIABILITIES

Non-current liabilities

Deferred tax liabilities

1,305,237

1,279,852

Long term provisions

9,968

7,314

1,315,205

1,287,166

Current liabilities

Trade and other payables

2,411,524

2,500,524

Short term provisions

31,987

33,922

Current tax liabilities

-

665

2,443,421

2,535,111

Total liabilities

3,758,626

3,822,277

Net assets

15,821,514

14,300,639

EQUITY

Capital and reserves

Share capital

739,000

739,000

Share premium account

3,693,818

3,693,818

Capital redemption reserve

256,976

256,976

Cumulative translation reserve

78,641

15,723

Profit and loss account

11,053,079

9,595,122

Equity attributable to equity holders of the parent

15,821,514

14,300,639

Total equity

15,821,514

14,300,639

 

Consolidated Cash Flow Statement

Year to

Year to

31 December

31 December

2015

2014

£

£

Cash flows from operating activities

Profit before tax for the period

2,733,417

1,723,846

Adjustments for:

Finance income

(42,292)

(58,079)

Depreciation

224,778

178,059

Amortisation

1,254,083

1,160,940

Impairment loss

690,201

450,000

Profit on disposal of property, plant and equipment (PPE)

(1,334)

-

Share-based payment

26,192

6,279

Exchange differences

86,711

29,060

Increase in inventories

(1,074,627)

(149,102)

Decrease in trade and other receivables

269,853

83,928

Increase/(decrease) in trade and other payables

(88,371)

563,828

Cash generated from operations

4,078,611

3,988,759

Tax (paid)/received

48,956

284

Net cash generated from operating activities

4,127,567

3,989,043

Cash flows from investing activities

Interest received

42,292

58,079

Cash released from/(placed) on Deposit

(1,000,000)

2,602,689

Purchases of property, plant and equipment (PPE)

(305,874)

(303,816)

Proceeds from sale of PPE

1,500

-

Capitalisation of development costs and purchases of intangible assets

(2,231,637)

(2,161,809)

Net cash used in investing activities

(3,493,719)

195,143

Cash flows from financing activities

Equity dividends paid

(1,343,141)

(1,257,305)

Issue of Ordinary shares

-

300,001

Purchase of treasury shares

(15,461)

-

Net cash used in financing activities

(1,358,602)

(957,304)

Effects of exchange rate changes on cash and cash equivalents

(25,936)

56,764

Net increase/(decrease) in cash

(750,690)

3,283,646

Cash at beginning of period

5,624,505

2,340,859

Cash at the end of the period

4,873,815

5,624,505

 

Consolidated Statement of Changes in Equity

Capital

Cumulative

Profit

Share

Share

redemption

translation

and loss

Total

capital

premium

reserve

reserve

account

Equity

£

£

£

£

£

£

Balance at 1 January 2014

727,000

 3,405,817

256,976

(74,816)

9,212,552

13,527,529

Profit for the period

-

-

-

-

1,647,698

1,647,698

Exchange differences on translating foreign operations

-

-

-

90,539

-

90,539

Total comprehensive income for the period

-

-

-

90,539

1,647,698

1,738,237

Transactions with owners:

Share-based payment

-

-

-

-

6,279

6,279

Deferred tax on share based payment

-

-

-

-

(14,102)

(14,102)

Dividends paid

-

-

-

-

(1,257,305)

(1,257,305)

Issue of Ordinary shares

12,000

288,001

-

-

-

300,001

Balance at 31 December 2014

739,000

3,693,818

256,976

15,723

9,595,122

14,300,639

Profit for the period

-

-

-

-

2,754,768

2,754,768

Exchange differences on translating foreign operations

-

-

-

62,918

-

62,918

Total comprehensive income for the period

-

-

-

62,918

2,754,768

2,817,686

Transactions with owners:

Share-based payment

-

-

-

-

26,192

26,192

Deferred tax on share based payment

-

-

-

-

35,599

35,599

Dividends paid

-

-

-

-

(1,343,141)

(1,343,141)

Purchase of Ordinary shares

-

-

-

-

(15,461)

(15,461)

Balance at 31 December 2015

739,000

3,693,818

256,976

78,641

11,053,079

15,821,514

 

NOTES

 

1. The Group financial statements consolidate those of the Company and its subsidiaries (together referred to as the 'Group'). The financial information set out in these preliminary results has been prepared in accordance with International Financial Reporting Standards ('IFRSs') as adopted by European Union. The accounting policies adopted in this results announcement have been consistently applied to all the years presented and are consistent with the policies used in the preparation of the statutory accounts for the period ended 31 December 2014. The consolidated financial information is presented in sterling (£), which is the company's functional and the Group's presentation currency.

 

2. The financial information set out above does not constitute the Group's statutory accounts for the years ended 31 December 2015 or 2014, but is derived from those accounts. Statutory accounts for 2014 have been delivered to the Registrar of Companies and those for 2015 will be delivered following the Annual General Meeting. The auditors have reported on those accounts; their reports were (i) unqualified, (ii) did not contain statements under section 498(2) or (3) of the Companies Act 2006 in respect of 2014 or 2015 and (iii) did not draw attention to any matters by way of emphasis.

 

3. The calculation of basic earnings per share is based on the weighted average number of Ordinary Shares in issue during 2015 of 72,594,150 (2014: 72,278,298) allowing for any adjustment made as a consequence of the Company having issued no Ordinary Shares during 2015 (2014: 1,200,000) and on the profit after tax for 2015 of £2,754,768 (2014: £1,647,698). The calculation of diluted earnings per share incorporates nil Ordinary Shares (2014: 11,992) in respect of performance related employee share options. The profit after tax is the same as for basic earnings per share.

 

4. The annual general meeting of Concurrent Technologies Plc will be held at the Company's offices at 4 Gilberd Court, Newcomen Way, Colchester, Essex, CO4 9WN, on 19 May 2016 at 2:30pm.

 

Copies of the Annual Report will be sent to Shareholders and will also be available from the Company's Registered Office: 4, Gilberd Court, Newcomen Way, Colchester, Essex, CO4 9WN, UK, and on the Company's website: www.cct.co.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR EAPDXFFXKEFF
Date   Source Headline
28th Dec 200710:52 amRNSDirector/PDMR Shareholding
27th Dec 20074:06 pmRNSDirector/PDMR Shareholding
24th Dec 200710:58 amRNSTransaction in Own Shares
21st Dec 200712:31 pmRNSTransaction in Own Shares
19th Dec 200711:28 amRNSTransaction in Own Shares
17th Dec 20074:41 pmPRNProduct Launch
5th Dec 20071:16 pmRNSDirector/PDMR Shareholding
3rd Dec 20073:31 pmPRNProduct Launch
30th Nov 20079:31 amRNSTotal Voting Rights
28th Nov 200711:07 amRNSTransaction in Own Shares
23rd Nov 20079:33 amRNSTransaction in Own Shares
22nd Nov 200710:14 amRNSTransaction in Own Shares
21st Nov 200711:15 amRNSTransaction in Own Shares
20th Nov 20071:17 pmRNSTransaction in Own Shares
19th Nov 20074:19 pmRNSHolding(s) in Company
19th Nov 200711:31 amRNSHolding(s) in Company
14th Nov 20073:46 pmRNSTransaction in Own Shares
14th Nov 200712:47 pmRNSTransaction in Own Shares
13th Nov 200710:00 amRNSTransaction in Own Shares
12th Nov 20073:57 pmRNSTransaction in Own Shares
31st Oct 20073:37 pmRNSTotal Voting Rights
24th Oct 20077:00 amPRNProduct Launch
17th Oct 20073:00 pmRNSTransaction in Own Shares
15th Oct 200710:21 amRNSTransaction in Own Shares
3rd Oct 20072:22 pmRNSTransaction in Own Shares
3rd Oct 20077:00 amRNSTransaction in Own Shares
28th Sep 20073:40 pmRNSTotal Voting Rights
21st Sep 20072:16 pmRNSDirector/PDMR Shareholding
21st Sep 200710:22 amRNSTransaction in Own Shares
20th Sep 20074:36 pmRNSDirector/PDMR Shareholding
19th Sep 20075:27 pmRNSDirector/PDMR Shareholding
19th Sep 20077:00 amPRNInterim Results
18th Sep 20072:56 pmPRNProduct Launch
11th Sep 200712:38 pmPRNNotice of Interim Results
6th Sep 200710:33 amPRNProduct Launch
28th Aug 20073:35 pmPRNProduct Launch
17th Aug 20073:22 pmRNSAIM Rule 26
8th Aug 20074:45 pmRNSHolding(s) in Company
31st Jul 20079:08 amRNSTotal Voting Rights
20th Jul 200710:55 amPRNProduct Launch
6th Jul 20074:17 pmRNSTransaction in Own Shares
27th Jun 20074:06 pmRNSDirector/PDMR Shareholding
19th Jun 20079:06 amRNSDirector/PDMR Shareholding
1st Jun 20073:53 pmPRNProduct Launch
23rd May 200711:10 amRNSHolding(s) in Company
15th May 20075:43 pmRNSHolding(s) in Company
18th Apr 200711:17 amPRNProduct Launch
23rd Mar 20075:05 pmRNSHolding(s) in Company
22nd Mar 20074:25 pmRNSHolding(s) in Company
22nd Mar 20074:19 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.